Get started
Author

Eric Tu

Regulatory T cells in cardiovascular diseases
2015 · Xiao Meng, Jianmin Yang, et al. · Nature Reviews Cardiology · 404
High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine Activation
2019 · Dunfang Zhang, Wenwen Jin, et al. · Immunity · 275
PDF
The mucosal immune system in the oral cavity—an orchestra of T cell diversity
2014 · Rui-Qing Wu, Dun-Fang Zhang, et al. · International Journal of Oral Science · 171
PDF
Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC
2022 · Eric Tu, Kelly McGlinchey, et al. · JCI Insight · 117
PDF
T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation
2018 · Eric Tu, Cheryl P.Z. Chia, et al. · Immunity · 100
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
2015 · Hiroko Nakatsukasa, Dunfang Zhang, et al. · Nature Immunology · 80
TGFβ in T cell biology and tumor immunity: Angel or devil?
2014 · Eric Tu, Pei Zhi Cheryl Chia, et al. · Cytokine & Growth Factor Reviews · 61
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
2023 · Peter Zanvit, Dewald van Dyk, et al. · Journal of Clinical Investigation · 59
PDF
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC).
2024 · Qi Zhang, Qihan Fu, et al. · Journal of Clinical Oncology · 56
Extracellular Vesicles from Apoptotic Cells Promote TGFβ Production in Macrophages and Suppress Experimental Colitis
2019 · Hua Chen, Shimpei Kasagi, et al. · Scientific Reports · 55
PDF
Manipulating Regulatory T Cells: A Promising Strategy to Treat Autoimmunity
2015 · Dunfang Zhang, Eric Tu, et al. · Immunotherapy · 40
PARP-1 regulates expression of TGF-β receptors in T cells
2013 · Pin Zhang, Hiroko Nakatsukasa, et al. · Blood · 39
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
2024 · Diwakar Davar, Benedito A Carneiro, et al. · Journal for ImmunoTherapy of Cancer · 30
PDF
Autoimmune Gastritis and Pernicious Anemia
2013 · Ian R. van Driel, Eric Tu, et al. · Elsevier eBooks · 28
Both IFN ‐γ and IL ‐17 are required for the development of severe autoimmune gastritis
2012 · Eric Tu, Desmond K.Y. Ang, et al. · European Journal of Immunology · 27
Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells
2013 · Eric Tu, Dorothée Bourges, et al. · European Journal of Immunology · 14
PDF
A Convenient Model of Severe, High Incidence Autoimmune Gastritis Caused by Polyclonal Effector T Cells and without Perturbation of Regulatory T Cells
2011 · Eric Tu, Desmond K. Y. Ang, et al. · PLoS ONE · 5
PDF
IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors
2025 · John Powderly, Martina Imbimbo, et al. · Cancer Research Communications · 4
PDF
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2026 · Qi Zhang, Qihan Fu, et al. · Nature · 3
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer
2024 · Amanda Rosewell Shaw, Daisuke Morita, et al. · Molecular Therapy Oncology · 3
Abstract LB085: Antitumor activity of AZD0754, a dnTGFbRII armored STEAP2 targeted CAR-T therapy, in preclinical models of prostate cancer
2023 · Dewald van Dyk, Peter Zanvit, et al. · Cancer Research · 2
Abstract 2837: Synthetic TGFb blockade preserves effector function and maintains stemness of GPC3 CAR-T against hepatocellular carcinoma
2022 · Nina J. Chu, Michael G. Overstreet, et al. · Cancer Research · 2
Abstract 3793: Advancing GPC3-positive solid tumor therapy with AZD9793, a novel CD8-guided T cell engager with potent pre-clinical efficacy and superior therapeutic index over GPC3 x CD3 formats
2025 · Cristina Bergamaschi, Cerys Lovatt, et al. · Cancer Research · 1
1058 Development of AZD9793 for GPC3+ solid tumor treatment: a next generation CD8-guided T cell engager with superior therapeutic index versus conventional formats
2024 · Cristina Bergamaschi, Upneet K Sokhi, et al. · Regular and Young Investigator Award Abstracts · 1
339 Quantitative assessment of CAR-T cell therapy targets using computational pathology
2022 · Nathalie Harder, Markus Schick, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Works count: 48
Citation count: 1,579
H-index: 15
I10-index: 16
Year
Topic
Type